Research programme: PIN1 inhibitors - PfizerAlternative Names: AG 122005
Latest Information Update: 04 Aug 2009
At a glance
- Originator Pfizer
- Mechanism of Action Pin1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 04 Aug 2009 Programme is in active development with Pfizer in the US